ArticleJournal of clinical medicine2026

AL Amyloidosis Patients Continue to Benefit from HDCT/ASCT Consolidation in the Daratumumab Era.

Julia Bee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.